Liminal BioSciences Inc. Skyrocketed

Wed, Jul 01, 2020 at 05:32 PM

Liminal BioSciences Inc. (LMNL:NASDAQ) jumped higher at $22.79, a gain of 117%. The stock got featured on our News Catalysts scanner on Wed 01 Jul 20 at 10:56 AM in the 'MISCELLANEOUS' category. From Tue 16 Jun 20, the stock recorded 50.00% Up Days and 54.55% Green Days

The share price of the company has been moving sideways in recent weeks.

About Liminal BioSciences Inc. (LMNL:NASDAQ)

Liminal Biosciences Inc is a global biopharmaceutical corporation supplying technologies for Bioseparations while also developing its orphan drugs, plasma-derived therapeutics and small-molecule therapeutic products targeting unmet medical needs in the field of fibrosis, autoimmune disease/inflammation, and cancer. The company also offers drug purification of biologics, drug development, proteomics and the elimination of pathogens.

Top 10 Gainers:

MYOS RENS Technology Inc. (MYOS:NASDAQ), 177.27%
Liminal BioSciences Inc. (LMNL:NASDAQ), 117.05%
YRC Worldwide Inc. (YRCW:NASDAQ), 74.59%
Sunworks, Inc. (SUNW:NASDAQ), 72.13%
Martin Midstream Partners L.P. (MMLP:NASDAQ), 63.87%
Alterity Therapeutics Limited (ATHE:NASDAQ), 57.14%
89bio, Inc. (ETNB:NASDAQ), 41.34%
Akero Therapeutics, Inc. (AKRO:NASDAQ), 33.91%
Luokung Technology Corp. (LKCO:NASDAQ), 29.55%
Western Copper and Gold Corporation (WRN:NYSEMKT), 28.46%